MAFG Human (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAFG mRNA CTD PMID:22079256 MAFG Human (E)-cinnamyl alcohol increases expression EXP 6480464 cinnamyl alcohol results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human 1,2-dimethylhydrazine increases expression ISO Mafg (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of MAFG mRNA CTD PMID:22206623 MAFG Human 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human 17alpha-ethynylestradiol increases expression ISO Mafg (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of MAFG mRNA CTD PMID:17942748 MAFG Human 17alpha-ethynylestradiol increases expression ISO Mafg (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of MAFG mRNA CTD PMID:29097150 MAFG Human 17alpha-ethynylestradiol multiple interactions ISO Mafg (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAFG mRNA CTD PMID:17942748 MAFG Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Mafg (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAFG mRNA CTD PMID:21570461 and PMID:24058054 MAFG Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Mafg (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAFG mRNA CTD PMID:33387578 MAFG Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Mafg (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of MAFG mRNA CTD PMID:34747641 MAFG Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Mafg (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAFG mRNA CTD PMID:37172768 MAFG Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAFG mRNA CTD PMID:26238291 MAFG Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Mafg (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAFG mRNA CTD PMID:17942748 MAFG Human 2,6-dinitrotoluene affects expression ISO Mafg (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of MAFG mRNA CTD PMID:21346803 MAFG Human 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human 2-tert-butylhydroquinone decreases expression EXP 6480464 2-tert-butylhydroquinone results in decreased expression of MAFG mRNA CTD PMID:35724838 MAFG Human 3,4-methylenedioxymethamphetamine affects expression ISO Mafg (Rattus norvegicus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine affects the expression of MAFG mRNA CTD PMID:30071829 MAFG Human 4-amino-2,6-dinitrotoluene affects expression ISO Mafg (Rattus norvegicus) 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of MAFG mRNA CTD PMID:21346803 MAFG Human 4-hydroxynon-2-enal increases expression ISO Mafg (Mus musculus) 6480464 4-hydroxy-2-nonenal results in increased expression of MAFG mRNA CTD PMID:19191707 MAFG Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAFG mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MAFG mRNA CTD PMID:32699268 MAFG Human acrolein affects expression ISO Mafg (Rattus norvegicus) 6480464 Acrolein affects the expression of MAFG mRNA CTD PMID:38090360 MAFG Human acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MAFG mRNA CTD PMID:32763439 MAFG Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of MAFG mRNA CTD PMID:23724009 MAFG Human alpha-hexylcinnamaldehyde increases expression EXP 6480464 hexyl cinnamic aldehyde results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAFG mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MAFG mRNA CTD PMID:32699268 MAFG Human amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of MAFG mRNA CTD PMID:19774075 and PMID:36586010 MAFG Human ammonium chloride affects expression ISO Mafg (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of MAFG mRNA CTD PMID:16483693 MAFG Human andrographolide decreases expression EXP 6480464 andrographolide results in decreased expression of MAFG mRNA CTD PMID:35724838 MAFG Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of MAFG mRNA CTD PMID:33212167 MAFG Human arotinoid acid multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 MAFG Human azoxystrobin decreases expression EXP 6480464 azoxystrobin results in decreased expression of MAFG mRNA CTD PMID:33512557 MAFG Human Bandrowski's base increases expression EXP 6480464 Bandrowski's base results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human Bardoxolone methyl affects expression EXP 6480464 bardoxolone methyl affects the expression of MAFG mRNA CTD PMID:34480604 MAFG Human Bardoxolone methyl decreases expression EXP 6480464 bardoxolone methyl results in decreased expression of MAFG mRNA CTD PMID:35724838 MAFG Human benzene decreases expression EXP 6480464 Benzene results in decreased expression of MAFG mRNA CTD PMID:33064461 MAFG Human benzo[a]pyrene increases expression ISO Mafg (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MAFG mRNA CTD PMID:21569818 and PMID:21715664 MAFG Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of MAFG 3' UTR more ... CTD PMID:27901495 MAFG Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MAFG mRNA CTD PMID:22316170 and PMID:26238291 MAFG Human benzoic acid increases expression EXP 6480464 Benzoic Acid results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of MAFG mRNA CTD PMID:32151702 and PMID:32858204 MAFG Human bisphenol A increases expression ISO Mafg (Rattus norvegicus) 6480464 bisphenol A results in increased expression of MAFG mRNA CTD PMID:25181051 MAFG Human bisphenol A decreases expression ISO Mafg (Mus musculus) 6480464 bisphenol A results in decreased expression of MAFG mRNA CTD PMID:32156529 MAFG Human bisphenol A multiple interactions EXP 6480464 [[ginger extract results in increased abundance of Oils and Volatile] which co-treated with bisphenol A] affects the expression of MAFG protein CTD PMID:33376534 MAFG Human bisphenol A decreases expression ISO Mafg (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of MAFG mRNA CTD PMID:34947998 MAFG Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAFG protein CTD PMID:33376534 MAFG Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAFG mRNA CTD PMID:29275510 MAFG Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAFG mRNA CTD PMID:30903817 MAFG Human bisphenol A increases methylation ISO Mafg (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of MAFG gene CTD PMID:28505145 MAFG Human bisphenol A affects methylation ISO Mafg (Mus musculus) 6480464 bisphenol A affects the methylation of MAFG promoter CTD PMID:27334623 MAFG Human bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of MAFG mRNA CTD PMID:20977926 MAFG Human butan-1-ol multiple interactions EXP 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MAFG mRNA CTD PMID:29432896 MAFG Human cadmium atom multiple interactions ISO Mafg (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAFG mRNA CTD PMID:37325564 MAFG Human cadmium dichloride increases expression ISO Mafg (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of MAFG mRNA CTD PMID:19010381 more ... MAFG Human cadmium dichloride multiple interactions ISO Mafg (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAFG mRNA CTD PMID:37325564 MAFG Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MAFG mRNA CTD PMID:11162468 more ... MAFG Human cadmium sulfate increases expression EXP 6480464 cadmium sulfate results in increased expression of MAFG mRNA CTD PMID:12064557 and PMID:21783983 MAFG Human cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of MAFG mRNA CTD PMID:31518892 MAFG Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAFG gene] CTD PMID:28238834 MAFG Human chenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA CTD PMID:32152650 MAFG Human CHIR 99021 multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 MAFG Human chloroacetaldehyde increases expression EXP 6480464 chloroacetaldehyde results in increased expression of MAFG mRNA CTD PMID:25596134 MAFG Human chloroprene increases expression ISO Mafg (Mus musculus) 6480464 Chloroprene results in increased expression of MAFG mRNA CTD PMID:23125180 MAFG Human chlorpyrifos decreases expression ISO Mafg (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of MAFG mRNA CTD PMID:37019170 MAFG Human cinnamyl alcohol increases expression EXP 6480464 cinnamyl alcohol results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of MAFG mRNA CTD PMID:33545341 MAFG Human clodronic acid increases expression EXP 6480464 Clodronic Acid results in increased expression of MAFG mRNA CTD PMID:25596134 MAFG Human clofibrate decreases expression ISO Mafg (Mus musculus) 6480464 Clofibrate results in decreased expression of MAFG mRNA CTD PMID:17585979 MAFG Human cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of MAFG mRNA CTD PMID:19320972 MAFG Human copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAFG mRNA and [Organoselenium Compounds binds to Copper] which results in increased expression of MAFG mRNA CTD PMID:20971185 and PMID:25167922 MAFG Human copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAFG mRNA and [Organoselenium Compounds binds to Copper] which results in increased expression of MAFG mRNA CTD PMID:20971185 and PMID:25167922 MAFG Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of MAFG mRNA CTD PMID:17211630 and PMID:38568856 MAFG Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of MAFG mRNA CTD PMID:19549813 MAFG Human cortisol multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 MAFG Human CU-O LINKAGE increases expression EXP 6480464 cupric oxide results in increased expression of MAFG mRNA CTD PMID:22077320 MAFG Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of MAFG mRNA CTD PMID:20106945 more ... MAFG Human cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA CTD PMID:32152650 MAFG Human cyclosporin A decreases expression ISO Mafg (Rattus norvegicus) 6480464 Cyclosporine results in decreased expression of MAFG mRNA CTD PMID:25596134 MAFG Human DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of MAFG mRNA CTD PMID:38568856 MAFG Human deoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA CTD PMID:32152650 MAFG Human dibutyl phthalate increases expression ISO Mafg (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of MAFG mRNA CTD PMID:21266533 MAFG Human dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of MAFG mRNA CTD PMID:28302478 MAFG Human diethyl malate increases expression EXP 6480464 diethyl malate results in increased expression of MAFG mRNA CTD PMID:38498338 MAFG Human diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of MAFG mRNA CTD PMID:33545341 and PMID:34480604 MAFG Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of MAFG mRNA CTD PMID:25596134 MAFG Human disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of MAFG mRNA CTD PMID:18175754 MAFG Human disulfiram increases expression EXP 6480464 Disulfiram results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 MAFG Human doxorubicin decreases expression ISO Mafg (Mus musculus) 6480464 Doxorubicin results in decreased expression of MAFG mRNA CTD PMID:19277126 MAFG Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of MAFG mRNA CTD PMID:29803840 MAFG Human endosulfan increases expression ISO Mafg (Rattus norvegicus) 6480464 Endosulfan results in increased expression of MAFG mRNA CTD PMID:29391264 MAFG Human eugenol increases expression EXP 6480464 Eugenol results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human fenofibrate decreases expression ISO Mafg (Rattus norvegicus) 6480464 Fenofibrate results in decreased expression of MAFG mRNA CTD PMID:25596134 MAFG Human fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of MAFG mRNA CTD PMID:25596134 MAFG Human fenthion decreases expression ISO Mafg (Mus musculus) 6480464 Fenthion results in decreased expression of MAFG mRNA CTD PMID:34813904 MAFG Human flutamide increases expression ISO Mafg (Rattus norvegicus) 6480464 Flutamide results in increased expression of MAFG mRNA CTD PMID:24136188 MAFG Human folic acid decreases expression ISO Mafg (Mus musculus) 6480464 Folic Acid results in decreased expression of MAFG mRNA CTD PMID:25629700 MAFG Human gentamycin increases expression ISO Mafg (Rattus norvegicus) 6480464 Gentamicins results in increased expression of MAFG mRNA CTD PMID:33387578 MAFG Human geraniol increases expression EXP 6480464 geraniol results in increased expression of MAFG mRNA CTD PMID:27683099 MAFG Human glycochenodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA CTD PMID:32152650 MAFG Human glycocholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA CTD PMID:32152650 MAFG Human glycodeoxycholic acid multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA CTD PMID:32152650 MAFG Human hexane increases expression EXP 6480464 n-hexane results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of MAFG mRNA CTD PMID:20044591 MAFG Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of MAFG mRNA CTD PMID:12414654 MAFG Human hypochlorous acid increases expression EXP 6480464 Hypochlorous Acid results in increased expression of MAFG mRNA CTD PMID:18156441 MAFG Human ibuprofen decreases expression ISO Mafg (Rattus norvegicus) 6480464 Ibuprofen results in decreased expression of MAFG mRNA CTD PMID:25596134 MAFG Human ifosfamide increases expression EXP 6480464 Ifosfamide results in increased expression of MAFG mRNA CTD PMID:25596134 MAFG Human iron dichloride increases expression EXP 6480464 ferrous chloride results in increased expression of MAFG mRNA CTD PMID:35984750 MAFG Human isoeugenol increases expression EXP 6480464 isoeugenol results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human L-ascorbic acid multiple interactions EXP 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of MAFG mRNA CTD PMID:34480604 MAFG Human L-ascorbic acid 2-phosphate multiple interactions EXP 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MAFG mRNA CTD PMID:34480604 MAFG Human lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of MAFG mRNA CTD PMID:38568856 MAFG Human lead(0) decreases expression EXP 6480464 Lead results in decreased expression of MAFG mRNA CTD PMID:19921347 MAFG Human lead(0) increases expression EXP 6480464 Lead results in increased expression of MAFG mRNA CTD PMID:37386098 MAFG Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of MAFG mRNA CTD PMID:28988120 MAFG Human lithocholic acid multiple interactions EXP 6480464 Lithocholic Acid results in increased expression of and results in increased activity of MAFG protein more ... CTD PMID:20146260 MAFG Human menadione increases expression EXP 6480464 Vitamin K 3 results in increased expression of MAFG mRNA CTD PMID:12414654 MAFG Human menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of MAFG mRNA CTD PMID:20044591 MAFG Human mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of MAFG mRNA CTD PMID:26272509 MAFG Human mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFG mRNA CTD PMID:27188386 MAFG Human metformin increases expression ISO Mafg (Rattus norvegicus) 6480464 Metformin results in increased expression of MAFG mRNA CTD PMID:25596134 MAFG Human methidathion decreases expression ISO Mafg (Mus musculus) 6480464 methidathion results in decreased expression of MAFG mRNA CTD PMID:34813904 MAFG Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of MAFG mRNA CTD PMID:23649840 MAFG Human methyl salicylate increases expression EXP 6480464 methyl salicylate results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human methylmercury chloride increases expression ISO Mafg (Mus musculus) 6480464 methylmercuric chloride results in increased expression of MAFG mRNA CTD PMID:20061341 MAFG Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of MAFG mRNA CTD PMID:23179753 and PMID:28001369 MAFG Human methylparaben increases expression EXP 6480464 methylparaben results in increased expression of MAFG mRNA CTD PMID:31745603 MAFG Human nefazodone multiple interactions EXP 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFG mRNA CTD PMID:32152650 MAFG Human nefazodone increases expression EXP 6480464 nefazodone results in increased expression of MAFG mRNA CTD PMID:32152650 MAFG Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of MAFG mRNA CTD PMID:32905824 MAFG Human organoselenium compound multiple interactions EXP 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of MAFG mRNA CTD PMID:25167922 MAFG Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAFG mRNA more ... CTD PMID:32699268 and PMID:35430440 MAFG Human p-chloromercuribenzoic acid increases expression EXP 6480464 p-Chloromercuribenzoic Acid results in increased expression of MAFG mRNA CTD PMID:26272509 MAFG Human p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFG mRNA CTD PMID:27188386 MAFG Human paracetamol increases expression ISO Mafg (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of MAFG mRNA CTD PMID:33387578 MAFG Human paraquat increases expression EXP 6480464 Paraquat results in increased expression of MAFG mRNA CTD PMID:35182771 MAFG Human pentachlorophenol increases expression ISO Mafg (Mus musculus) 6480464 Pentachlorophenol results in increased expression of MAFG mRNA CTD PMID:23892564 MAFG Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of MAFG mRNA CTD PMID:19159669 MAFG Human phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of MAFG mRNA CTD PMID:26272509 MAFG Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFG mRNA CTD PMID:27188386 MAFG Human phlorizin decreases expression ISO Mafg (Mus musculus) 6480464 Phlorhizin results in decreased expression of MAFG mRNA CTD PMID:22538082 MAFG Human phorone affects expression ISO Mafg (Rattus norvegicus) 6480464 phorone affects the expression of MAFG mRNA CTD PMID:18198479 MAFG Human picoxystrobin decreases expression EXP 6480464 picoxystrobin results in decreased expression of MAFG mRNA CTD PMID:33512557 MAFG Human potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAFG mRNA CTD PMID:22079256 MAFG Human potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of MAFG mRNA CTD PMID:22079256 MAFG Human propan-2-ol increases expression EXP 6480464 2-Propanol results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human propiconazole decreases expression ISO Mafg (Mus musculus) 6480464 propiconazole results in decreased expression of MAFG mRNA CTD PMID:21278054 MAFG Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of MAFG mRNA CTD PMID:21632981 MAFG Human rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human reactive oxygen species affects expression EXP 6480464 Reactive Oxygen Species affects the expression of MAFG mRNA CTD PMID:25800948 MAFG Human rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAFG mRNA CTD PMID:33512557 MAFG Human rotenone increases expression EXP 6480464 Rotenone results in increased expression of MAFG mRNA CTD PMID:36586010 MAFG Human S-(1,2-dichlorovinyl)-L-cysteine increases expression EXP 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of MAFG mRNA CTD PMID:33725128 MAFG Human S-adenosyl-L-methioninate multiple interactions EXP 6480464 S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein] and S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein]] CTD PMID:20146260 MAFG Human S-adenosyl-L-methionine multiple interactions EXP 6480464 S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein] and S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein]] CTD PMID:20146260 MAFG Human SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:34480604 MAFG Human silver atom increases expression EXP 6480464 Silver results in increased expression of MAFG mRNA CTD PMID:26014281 MAFG Human silver(0) increases expression EXP 6480464 Silver results in increased expression of MAFG mRNA CTD PMID:26014281 MAFG Human sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of MAFG protein CTD PMID:12220541 MAFG Human sodium arsenite multiple interactions EXP 6480464 sodium arsenite promotes the reaction [MAFG protein binds to HSF1 promoter] and sodium arsenite promotes the reaction [MAFG protein binds to HSF1 protein] CTD PMID:30309986 MAFG Human sodium arsenite decreases expression ISO Mafg (Mus musculus) 6480464 sodium arsenite results in decreased expression of MAFG mRNA CTD PMID:19822182 MAFG Human sodium arsenite multiple interactions ISO Mafg (Mus musculus) 6480464 sodium arsenite promotes the reaction [[NFE2L2 protein binds to MAFG protein] which binds to NQO1 promoter] CTD PMID:16785233 MAFG Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MAFG mRNA CTD PMID:11162468 more ... MAFG Human sodium dodecyl sulfate increases expression EXP 6480464 Sodium Dodecyl Sulfate results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of MAFG mRNA CTD PMID:31838189 MAFG Human sulforaphane affects expression EXP 6480464 sulforaphane affects the expression of MAFG mRNA CTD PMID:35724838 MAFG Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of MAFG mRNA CTD PMID:31533062 MAFG Human tert-butyl hydroperoxide increases methylation EXP 6480464 tert-Butylhydroperoxide results in increased methylation of MAFG gene CTD PMID:27509014 MAFG Human tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of MAFG mRNA CTD PMID:12414654 and PMID:27509014 MAFG Human thiram increases expression EXP 6480464 Thiram results in increased expression of MAFG mRNA CTD PMID:38568856 MAFG Human titanium dioxide increases expression ISO Mafg (Mus musculus) 6480464 titanium dioxide results in increased expression of MAFG mRNA CTD PMID:23131501 MAFG Human trans-isoeugenol increases expression EXP 6480464 isoeugenol results in increased expression of MAFG mRNA CTD PMID:20566472 MAFG Human Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of MAFG mRNA CTD PMID:21601586 MAFG Human trichloroethene increases expression ISO Mafg (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of MAFG mRNA CTD PMID:33387578 MAFG Human triclosan increases methylation EXP 6480464 Triclosan results in increased methylation of MAFG gene CTD PMID:34523531 MAFG Human troglitazone decreases expression ISO Mafg (Rattus norvegicus) 6480464 troglitazone results in decreased expression of MAFG mRNA CTD PMID:25596134 MAFG Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of MAFG mRNA CTD PMID:36586010 MAFG Human urethane increases expression EXP 6480464 Urethane results in increased expression of MAFG mRNA CTD PMID:28818685 MAFG Human ursodeoxycholic acid multiple interactions EXP 6480464 S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein]] and Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein] CTD PMID:20146260 MAFG Human valproic acid affects expression ISO Mafg (Mus musculus) 6480464 Valproic Acid affects the expression of MAFG mRNA CTD PMID:17292431 MAFG Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of MAFG mRNA CTD PMID:28001369 MAFG Human valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of MAFG gene CTD PMID:29154799 MAFG Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of MAFG mRNA CTD PMID:25979313 MAFG Human XAV939 multiple interactions EXP 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MAFG mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of MAFG mRNA CTD PMID:34480604 MAFG Human zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAFG mRNA CTD PMID:18593933 MAFG Human zinc dichloride increases expression EXP 6480464 zinc chloride results in increased expression of MAFG mRNA CTD PMID:11162468 MAFG Human zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAFG mRNA CTD PMID:18593933
